Target intelligence / Profile preview

Generating flesh

Molecular classification
Other
01

Overview

"Generating flesh" is a functional therapeutic property primarily described in Traditional Chinese Medicine (TCM) as "Sheng Ji," rather than a specific molecular target such as a protein or receptor [1][4]. It refers to the physiological process of promoting wound healing, stimulating the growth of granulation tissue, and regenerating soft tissues (muscle and skin) in cases of chronic sores, ulcers, or non-healing wounds [4][5]. This multifaceted biological process involves the activation of multiple signaling pathways, including PI3K/Akt and MAPK, and the upregulation of various endogenous growth factors like VEGF and TGF-beta to facilitate fibroblast proliferation and collagen synthesis [1]. Because it describes a broad therapeutic outcome or macroscopic biological action rather than a discrete molecular entity, it is not classified as a therapeutic target in modern pharmacology [1]. Research into agents with this property focuses on their ability to accelerate tissue repair and improve the healing environment of damaged surfaces [5].

Other names
Sheng jiShengjiGranulation tissue formationTissue regenerationMyogenesisWound healing property
02

Mechanism of action

Promotion of wound closure and tissue repair via the induction of granulation tissue formation, collagen deposition, and enhancement of regional blood circulation, often through the activation of growth factor signaling pathways [1][4][5].

03

Biological functions

Wound healingTissue regenerationGranulationCell proliferationMyogenesis
04

Disease associations

WoundUlcerSoreTissue injuryAbscess
05

Safety considerations

Hypertrophic scarringExcessive granulation (proud flesh)Potential for promoting fibrosis
06

Interacting drugs

Astragalus membranaceus

4 more in the full profile.

07

Biomarkers

Vascular endothelial growth factor (VEGF)Transforming growth factor beta (TGF-beta)Collagen type I expressionFibroblast growth factor (FGF)

Beyond the preview

Go deeper on Generating flesh.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Generating flesh.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call